Craneware (LON:CRW) Stock Breaks Below 200-Day Moving Average – Here’s What Happened

Posted by Andrew Walz on Oct 11th, 2026

Shares of Craneware plc (LON:CRW – Get Free Report) crossed below its two hundred day moving average during trading on Friday. The stock has a two hundred day moving average of GBX 1,330.55 and traded as low as GBX 1,062. Craneware shares last traded at GBX 1,100, with a volume of 126,853 shares.

Analyst Upgrades and Downgrades

Separately, Berenberg Bank cut their target price on Craneware from GBX 2,600 to GBX 1,600 and set a “buy” rating on the stock in a research report on Monday, September 21st. Three analysts have rated the stock with a Buy rating. Based on data from MarketBeat.com, the stock has an average rating of “Buy” and an average target price of GBX 1,673.33.

Check Out Our Latest Stock Analysis on CRW

Craneware Stock Performance

The stock’s 50 day moving average price is GBX 1,236.38 and its 200 day moving average price is GBX 1,330.55. The company has a current ratio of 0.83, a quick ratio of 1.00 and a debt-to-equity ratio of 14.60. The firm has a market cap of £376.61 million, a PE ratio of 19.64 and a beta of 0.28.

Insiders Place Their Bets

In related news, insider Craig Preston sold 14,656 shares of the stock in a transaction on Tuesday, September 22nd. The stock was sold at an average price of GBX 1,035, for a total value of £151,689.60. Also, insider Susan Nelson bought 1,408 shares of the firm’s stock in a transaction dated Tuesday, September 22nd. The stock was bought at an average cost of GBX 1,054 per share, with a total value of £14,840.32. 1.23% of the stock is currently owned by corporate insiders.

About Craneware

(Get Free Report)

For over 25 years, The Craneware Group (AIM:CRW.L) has been a leader in healthcare financial and operational transformation, delivering cutting-edge technologies that drive measurable impact. Our Trisus® cloud ecosystem unifies data, revenue intelligence, margin intelligence, and advanced analytics, enabling healthcare organizations to optimize performance, improve financial sustainability, and drive strategic growth. As a trusted Microsoft partner, we provide future-ready solutions-including the Best in KLAS Trisus Chargemaster – that simplify the complexities of healthcare finance and operations.